Unlock instant, AI-driven research and patent intelligence for your innovation.

Recombinant virus of chimeric IBV H120 S1 gene ectodomain suitable for cell culture and construction method and application thereof

An IBVH120S1, cell culture technology, applied in microorganism-based methods, medical raw materials derived from viruses/phages, antiviral agents, etc., can solve the problems of exogenous virus contamination cost, small toxin production, and long production cycle.

Active Publication Date: 2015-03-18
LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] The technical problem to be solved by the present invention is to overcome the risk of exogenous virus contamination in the existing vaccine production process and the disadvantages of high cost, small toxin production, and long production cycle, and the main epitope of the current IBV H120 vaccine strain used for immunization Replacement of the corresponding gene segment of the IBV Beaudette strain adapted to Vero cell culture by the fragment of the outer membrane region of the S1 gene, and then construct the recombinant virus BeauR-H120 (S1)

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Recombinant virus of chimeric IBV H120 S1 gene ectodomain suitable for cell culture and construction method and application thereof
  • Recombinant virus of chimeric IBV H120 S1 gene ectodomain suitable for cell culture and construction method and application thereof
  • Recombinant virus of chimeric IBV H120 S1 gene ectodomain suitable for cell culture and construction method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Embodiment 1 Construction of IBV recombinant virus BeauR-H120 (S1) of the present invention

[0054] The specific construction method is completed by the following steps:

[0055] 1. Total RNA was extracted from IBV H120 vaccine strain and Beaudette P65 generation cytotoxicity with Trizol reagent (Invitrogen, USA). The downstream primers in Table 1 were used for reverse transcription, wherein primer Beau-H21711R was used for reverse transcription of the extramembrane region of S1 gene of IBV H120 strain. Primers Beau-5752R, Beau-8693R, Beau-15520R, Beau-20422R, and Beau-27608R were used for reverse transcription of the backbone fragment of the parent virus Beaudette strain.

[0056] The primer pair used when the recombinant virus BeauR-H120 (S1) was constructed in table 1

[0057]

[0058] 2. Use the primer pair Beau-H20421F and Beau-H21711R in Table 1 to amplify the extramembrane region fragment of the S1 gene of IBV H120 strain, and the resulting fragment is labe...

Embodiment 2

[0073] Embodiment 2 The cultivation of IBV recombinant virus BeauR-H120 (S1) of the present invention

[0074] 1 method

[0075] 1.1 Stable passage of rescued successful IBV recombinant virus

[0076] The successfully rescued recombinant virus was serially passaged on Vero cells. When the Vero cells just covered the cell bottle, inoculate 1 mL of the recombinant virus solution that was repeatedly frozen and thawed 3 times, and add 4 mL of serum-free DMEM cell maintenance solution, and place at 37 ° C, 5% CO 2 Continue culturing in the cell culture incubator. The virus was harvested when 90% of the cells showed cytopathic changes, and the entire cell bottle was placed in a -70°C refrigerator for three times of repeated freezing and thawing, waiting for the next inoculation. 1mL cytotoxic RNA was extracted for each generation, and the presence of IBV genome was detected by RT-PCR.

[0077] 1.2 Determination of virus titer

[0078] Take the 5th, 10th, 15th, 18th, and 21st ge...

Embodiment 3IB

[0100] Immune efficacy evaluation of embodiment 3 IBV recombinant virus BeauR-H120 (S1)

[0101] 1 method

[0102] 1.1 IBV recombinant virus BeauR-H120 (S1) immune protection test

[0103] Randomly divide 40 1-day-old SPF chicks into A and B groups (20 / group), and raise them in negative pressure isolators respectively. At the age of 7 days, group A was inoculated with IBV BeauR-H120 (S1) cytotoxicity (21st generation) (10 6.25 EID 50 / 0.1mL), each eye drops 0.1mL. Group B was used as the control group, and 0.1 mL of normal Vero cell lysate was instilled in each eye. From the date of inoculation, observe and record the incidence of the vaccinated chickens every day, and 14 days and 21 days after immunization, blood was collected from the two groups of chickens, and the specific antibody was detected after the serum was separated. The specific method was carried out according to the instructions of the IBV antibody detection kit of IDEXX company in the United States. 21 da...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention discloses a recombinant virus of a chimeric IBV H120 S1 gene ectodomain suitable for cell culture and a construction method and application thereof. The recombinant virus is constructed by the following steps of: replacing the S1 gene ectodomain segment of an IBV Beaudette strain with an S1 gene ectodomain segment of an IBV H120 strain to construct the recombinant virus; after successful virus rescue, passing from the Vero cell; collecting toxicity when the cell cytopathic effect area is over 90%; and repeatedly freezing and thawing for three times, and continuing passage to obtain the recombinant virus of a chimeric IBV H120 S1 gene ectodomain suitable for cell culture. The recombinant virus disclosed by the invention is used as a vaccine strain to immunize SPF chicken; after counteracting toxicity, the chicken flocks of an immunity group and a control group are continuously observed to discover that the recombinant virus disclosed by the invention can serve as a vaccine strain to provide good immunity protection to the inoculated chicken; and the recombinant virus is safe to various kinds of chicken and avoids side reaction.

Description

technical field [0001] The present invention relates to a recombinant virus and its construction method and application, in particular to a chimeric IBV H120S1 gene membrane outer region recombinant virus suitable for cell culture and its construction method and its application in the prevention and treatment of chicken infectious bronchitis , The invention belongs to the technical field of veterinary drug research. Background technique [0002] Avian Infectious Bronchitis (IB) is an acute, highly contagious disease caused by Avian Infectious Bronchitis Virus (IBV). IBV is a single-stranded positive-sense RNA virus belonging to the Coronaviridae family. IBV can infect chickens of different ages, but the infection mainly affects chicks under 4 weeks old. The clinical manifestations are tracheal rales, coughing and sneezing; pale and swollen kidneys, a large amount of urate deposition and oviduct congestion. Main features, and can cause death, its resistance gradually increa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N7/01A61K35/765A61K39/12A61P31/14C12R1/93A61K35/76
Inventor 郭慧琛孙世琪魏衍全董虎王海明孙德惠刘定祥才学鹏殷宏
Owner LANZHOU INST OF VETERINARY SCI CHINESE ACAD OF AGRI SCI